CYPHERPUNK TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 11.67 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-12
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 544.16K shares, a 293.61% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 1.73M shares, a 2538.63% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 1.25M shares, a 2357.88% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 130.41K shares, a 5.72% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 3.65M shares, a 829.66% increase from fiscal 2024.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 392.92K shares, a 95.63% increase from fiscal 2023.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 200.85K shares, a 218.60% increase from fiscal 2022.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 63.04K shares, a 81.92% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 11.67K shares 10-Q · filed 2026-08-12 | ||||
| 2025-12-31 | 544.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 2.27M shares derived: sum of 2 quarters · filed 2026-03-16 | 3.52M shares derived: sum of 3 quarters · filed 2026-03-16 | 3.65M shares 10-K · filed 2026-03-16 | |
| 2025-09-30 | 1.73M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 2.98M shares derived: sum of 2 quarters · filed 2025-11-12 | 3.11M shares 10-Q · filed 2025-11-12 | 3.25M shares derived: sum of 4 quarters · filed 2026-03-16 | |
| 2025-06-30 | 1.25M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 1.38M shares 10-Q · filed 2025-08-14 | 1.52M shares derived: sum of 3 quarters · filed 2026-03-16 | 1.58M shares derived: sum of 4 quarters · filed 2026-03-16 | |
| 2025-03-31 | 130.41K shares 10-Q · filed 2025-05-13 | 268.66K shares derived: sum of 2 quarters · filed 2026-03-16 | 334.25K shares derived: sum of 3 quarters · filed 2026-03-16 | 385.01K shares derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-12-31 | 138.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 203.84K shares derived: sum of 2 quarters · filed 2026-03-16 | 254.60K shares derived: sum of 3 quarters · filed 2026-03-16 | 392.92K shares 10-K · filed 2026-03-16 | |
| 2024-09-30 | 65.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 116.35K shares derived: sum of 2 quarters · filed 2024-11-13 | 254.67K shares 10-Q · filed 2024-11-13 | 370.95K shares derived: sum of 4 quarters · filed 2025-03-26 | |
| 2024-06-30 | 50.76K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 189.09K shares 10-Q · filed 2024-08-12 | 305.37K shares derived: sum of 3 quarters · filed 2025-03-26 | 352.41K shares derived: sum of 4 quarters · filed 2025-03-26 | |
| 2024-03-31 | 138.32K shares 10-Q · filed 2024-05-13 | 254.61K shares derived: sum of 2 quarters · filed 2025-03-26 | 301.64K shares derived: sum of 3 quarters · filed 2025-03-26 | 275.00K shares derived: sum of 4 quarters · filed 2025-03-26 | |
| 2023-12-31 | 116.28K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 163.32K shares derived: sum of 2 quarters · filed 2025-03-26 | 136.68K shares derived: sum of 3 quarters · filed 2025-03-26 | 200.85K shares 10-K · filed 2025-03-26 | |
| 2023-09-30 | 47.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 20.39K shares derived: sum of 2 quarters · filed 2023-11-13 | 84.57K shares 10-Q · filed 2023-11-13 | -345.31K shares derived: sum of 4 quarters · filed 2024-03-18 | |
| 2023-06-30 | -26.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 37.53K shares 10-Q · filed 2023-08-14 | -392.34K shares derived: sum of 3 quarters · filed 2024-03-18 | -123.63K shares derived: sum of 4 quarters · filed 2024-03-18 | |
| 2023-03-31 | 64.17K shares 10-Q · filed 2023-05-15 | -365.70K shares derived: sum of 2 quarters · filed 2024-03-18 | -96.98K shares derived: sum of 3 quarters · filed 2024-03-18 | 53.10K shares derived: sum of 4 quarters · filed 2024-03-18 | |
| 2022-12-31 | -429.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -161.16K shares derived: sum of 2 quarters · filed 2024-03-18 | -11.07K shares derived: sum of 3 quarters · filed 2024-03-18 | 63.04K shares 10-K · filed 2024-03-18 | 633.19K shares 10-K · filed 2023-03-24 |
| 2022-09-30 | 268.72K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 418.80K shares derived: sum of 2 quarters · filed 2022-11-14 | 492.92K shares 10-Q · filed 2022-11-14 | 492.92K shares derived: sum of 4 quarters · filed 2023-03-24 | |
| 2022-06-30 | 150.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 224.20K shares 10-Q · filed 2022-08-12 | 224.20K shares derived: sum of 3 quarters · filed 2023-03-24 | 230.87K shares derived: sum of 4 quarters · filed 2023-03-24 | |
| 2022-03-31 | 74.11K shares 10-Q · filed 2022-05-13 | 74.11K shares derived: sum of 2 quarters · filed 2023-03-24 | 80.78K shares derived: sum of 3 quarters · filed 2023-03-24 | 222.66K shares derived: sum of 4 quarters · filed 2023-03-24 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | 6.67K shares derived: sum of 2 quarters · filed 2023-03-24 | 148.55K shares derived: sum of 3 quarters · filed 2023-03-24 | 348.59K shares 10-K · filed 2023-03-24 | |
| 2021-09-30 | 6.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 148.55K shares derived: sum of 2 quarters · filed 2021-11-12 | 348.59K shares 10-Q · filed 2021-11-12 | 348.59K shares derived: sum of 4 quarters · filed 2022-03-11 | |
| 2021-06-30 | 141.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | 341.93K shares 10-Q · filed 2021-08-13 | 341.93K shares derived: sum of 3 quarters · filed 2022-03-11 | 342.20K shares derived: sum of 4 quarters · filed 2022-03-11 | |
| 2021-03-31 | 200.05K shares 10-Q · filed 2021-05-14 | 200.05K shares derived: sum of 2 quarters · filed 2022-03-11 | 200.32K shares derived: sum of 3 quarters · filed 2022-03-11 | 269.90K shares derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | 278.00 shares derived: sum of 2 quarters · filed 2022-03-11 | 69.86K shares derived: sum of 3 quarters · filed 2022-03-11 | 260.44K shares 10-K · filed 2022-03-11 | |
| 2020-09-30 | 278.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 69.86K shares derived: sum of 2 quarters · filed 2020-11-12 | 260.44K shares 10-Q · filed 2020-11-12 | 260.44K shares derived: sum of 4 quarters · filed 2021-03-12 | |
| 2020-06-30 | 69.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 260.16K shares 10-Q · filed 2020-08-13 | 260.16K shares derived: sum of 3 quarters · filed 2021-03-12 | 307.05K shares derived: sum of 4 quarters · filed 2021-03-12 | |
| 2020-03-31 | 190.58K shares 10-Q · filed 2020-05-14 | 190.58K shares derived: sum of 2 quarters · filed 2021-03-12 | 237.47K shares derived: sum of 3 quarters · filed 2021-03-12 | 338.85K shares derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | 46.90K shares derived: sum of 2 quarters · filed 2021-03-12 | 148.27K shares derived: sum of 3 quarters · filed 2021-03-12 | 219.32K shares 10-K · filed 2021-03-12 | |
| 2019-09-30 | 46.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 148.27K shares derived: sum of 2 quarters · filed 2019-11-14 | 219.32K shares 10-Q · filed 2019-11-14 | 243.10K shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-06-30 | 101.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 172.43K shares 10-Q · filed 2019-08-09 | 196.21K shares derived: sum of 3 quarters · filed 2020-03-16 | 225.24K shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-03-31 | 71.05K shares 10-Q · filed 2019-05-15 | 94.84K shares derived: sum of 2 quarters · filed 2020-03-16 | 123.87K shares derived: sum of 3 quarters · filed 2020-03-16 | 155.79K shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-12-31 | 23.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 52.81K shares derived: sum of 2 quarters · filed 2020-03-16 | 84.74K shares derived: sum of 3 quarters · filed 2020-03-16 | 92.28K shares 10-K · filed 2020-03-16 | |
| 2018-09-30 | 29.03K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 60.96K shares derived: sum of 2 quarters · filed 2018-11-09 | 68.50K shares 10-Q · filed 2018-11-09 | 68.50K shares derived: sum of 4 quarters · filed 2019-04-01 | |
| 2018-06-30 | 31.93K shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-08 | 39.47K shares 10-Q · filed 2018-08-08 | 39.47K shares derived: sum of 3 quarters · filed 2019-04-01 | 40.57K shares derived: sum of 4 quarters · filed 2019-04-01 | |
| 2018-03-31 | 7.54K shares 10-Q/A · filed 2018-08-08 | 7.54K shares derived: sum of 2 quarters · filed 2019-04-01 | 8.64K shares derived: sum of 3 quarters · filed 2019-04-01 | 8.87K shares derived: sum of 4 quarters · filed 2019-04-01 | |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | 1.10K shares derived: sum of 2 quarters · filed 2019-04-01 | 1.33K shares derived: sum of 3 quarters · filed 2019-04-01 | 12.96K shares 10-K · filed 2019-04-01 | |
| 2017-09-30 | 1.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | 1.33K shares derived: sum of 2 quarters · filed 2017-11-13 | 12.96K shares 10-Q · filed 2017-11-13 | ||
| 2017-06-30 | 230.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | 11.86K shares 10-Q · filed 2017-08-11 | |||
| 2017-03-31 | 11.63K shares 10-Q · filed 2017-05-12 | ||||
| 2016-12-31 | 6.05K shares 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |